Common Stock, Shares, Outstanding of TG THERAPEUTICS, INC. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Tg Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2010 to Q3 2025.
  • Tg Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 155M shares, a 0.36% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

TG THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 155M -567K -0.36% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 158M +3.19M +2.06% 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 158M +3.6M +2.33% 31 Mar 2025 10-Q 09 May 2025
Q4 2024 156M +4.41M +2.91% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 156M +4.33M +2.86% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 155M +3.9M +2.59% 30 Jun 2024 10-Q 09 Aug 2024
Q1 2024 155M +5.17M +3.46% 31 Mar 2024 10-Q 06 May 2024
Q4 2023 151M +5.04M +3.44% 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 151M +6.09M +4.19% 30 Sep 2023 10-Q 06 Nov 2023
Q2 2023 151M +5.77M +3.98% 30 Jun 2023 10-Q 04 Aug 2023
Q1 2023 149M +4.85M +3.36% 31 Mar 2023 10-Q 08 May 2023
Q4 2022 146M +3.13M +2.19% 31 Dec 2022 10-K 29 Feb 2024
Q3 2022 145M +2.41M +1.69% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 145M +2.32M +1.63% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 145M +3.06M +2.17% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 143M +2.67M +1.9% 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 143M +14M +10.9% 30 Sep 2021 10-Q 08 Nov 2021
Q2 2021 143M +16.2M +12.8% 30 Jun 2021 10-Q 06 Aug 2021
Q1 2021 141M +31.3M +28.4% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 141M +31.2M +28.5% 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 129M +32.3M +33.4% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 127M +33.3M +35.7% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 110M +21.6M +24.4% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 109M +25.5M +30.4% 31 Dec 2019 10-K 01 Mar 2021
Q3 2019 96.6M +13.7M +16.5% 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 93.4M +10.9M +13.2% 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 88.5M +11.4M +14.8% 31 Mar 2019 10-Q 10 May 2019
Q4 2018 83.9M +10.7M +14.7% 31 Dec 2018 10-K 02 Mar 2020
Q3 2018 82.9M +12.3M +17.4% 30 Sep 2018 10-Q 09 Nov 2018
Q2 2018 82.5M +14.4M +21.2% 30 Jun 2018 10-Q 09 Aug 2018
Q1 2018 77.1M +10.3M +15.5% 31 Mar 2018 10-Q 10 May 2018
Q4 2017 73.1M +16.4M +28.8% 31 Dec 2017 10-K 01 Mar 2019
Q3 2017 70.7M +15.9M +29.1% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 68.1M +13.6M +25% 30 Jun 2017 10-Q 09 Aug 2017
Q1 2017 66.8M +12.7M +23.5% 31 Mar 2017 10-Q 10 May 2017
Q4 2016 56.8M +2.73M +5.04% 31 Dec 2016 10-K 15 Mar 2018
Q3 2016 54.7M +2.21M +4.2% 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 54.5M +2.8M +5.42% 30 Jun 2016 10-Q 09 Aug 2016
Q1 2016 54.1M +6.65M +14% 31 Mar 2016 10-Q 10 May 2016
Q4 2015 54.1M +9.12M +20.3% 31 Dec 2015 10-K 16 Mar 2017
Q3 2015 52.5M +11.1M +26.7% 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 51.7M +13.5M +35.5% 30 Jun 2015 10-Q 10 Aug 2015
Q1 2015 47.4M +9.95M +26.5% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 44.9M +10.6M +31% 31 Dec 2014 10-K 15 Mar 2016
Q3 2014 41.4M +8.04M +24.1% 30 Sep 2014 10-Q 14 Nov 2014
Q2 2014 38.1M +11.4M +42.7% 30 Jun 2014 10-Q 24 Jul 2014
Q1 2014 37.5M +11.2M +42.4% 31 Mar 2014 10-Q 14 May 2014
Q4 2013 34.3M +8.49M +32.9% 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 33.4M +13.3M +66.5% 30 Sep 2013 10-Q 14 Nov 2013
Q2 2013 26.7M +8.67M +48% 30 Jun 2013 10-Q 09 Aug 2013
Q1 2013 26.3M +21.3M +420% 31 Mar 2013 10-Q 14 May 2013
Q4 2012 25.8M +20.7M +410% 31 Dec 2012 10-K 07 Mar 2014
Q3 2012 20.1M +12.7M +171% 30 Sep 2012 10-Q 14 Nov 2012
Q2 2012 18.1M +15.5M +595% 30 Jun 2012 10-Q/A 07 Sep 2012
Q1 2012 5.06M 31 Mar 2012 10-Q 14 May 2012
Q4 2011 5.06M +2.64M +109% 31 Dec 2011 10-K 21 Mar 2013
Q3 2011 7.4M 30 Sep 2011 10-Q 14 Nov 2011
Q2 2011 2.6M 30 Jun 2011 10-Q/A 14 Sep 2011
Q4 2010 2.42M 31 Dec 2010 10-Q 14 Nov 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.